SCHEMBL24400355

SCHEMBL24400355

C[C@H](N)Cn1ccc2nc(Cl)nc(Cl)c21

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 20/20 0.47
HTR2A P28223 19/20 0.47
HTR2B P41595 6/20 0.47
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18359327 0.80 CYP19A1 (0.33)
SCHEMBL19661033 0.78 GRM2 (0.35)
SCHEMBL16484167 0.75 GRIN2B (0.36)
SCHEMBL24976554 0.75 HTR2A (0.47) HTR2A
SCHEMBL24976903 0.75 HTR2A (0.47) HTR2A
SCHEMBL30677346 0.75 IRAK4 (0.33)
SCHEMBL20996056 0.74 EGFR (0.33)
SCHEMBL19661198 0.73 PDE4B (0.38) CYP1A2CYP3A4
SCHEMBL1716185 0.73 TLR7 (0.46)
SCHEMBL24400358 0.73 TRPA1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4238974-A1 HIGH-ACTIVITY WNT PATHWAY INHIBITOR COMPOUND Adlai Nortye Biopharma Co., Ltd. (CN) 2023-09-06 EP disclosed
WO-2022089454-A1 HIGH-ACTIVITY WNT PATHWAY INHIBITOR COMPOUND 杭州阿诺生物医药科技有限公司 2022-05-05 WO disclosed